Svetlana Hanson
Internal Medicine · Destin, FLNPI 1275931727
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 35.9% of the total. Reporting peaked in 2019 at $1,178 and has fallen 71.9% since, to $331 in 2025.
Across 154 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$367
- Novo Nordisk$302
- Amgen$189
- AstraZeneca$135
- Merck$101
- plus $922 from 21 others
What the payments were for
- Food & beverage$3,138100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $1,130 |
| Lilly USA, LLC | 31 | $367 |
| Novo Nordisk | 19 | $302 |
| Amgen | 6 | $189 |
| AstraZeneca | 10 | $135 |
| Merck | 6 | $101 |
| Octapharma USA, Inc. | 2 | $90 |
| Eisai Inc. | 5 | $83 |
| Galderma Laboratories, L.p. | 1 | $78 |
| Amarin Pharma, Inc. | 4 | $76 |
| Dexcom, Inc. | 3 | $64 |
| Merz North America, Inc. | 2 | $57 |
| Upsher-smith Laboratories LLC | 3 | $51 |
| Nestle Healthcare Nutrition Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Pfizer | 3 | $37 |
| Shire North American Group Inc | 2 | $34 |
| Exact Sciences | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Neos Therapeutics, LP | 1 | $25 |
| Corium, LLC | 1 | $20 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,146 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Destin
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.